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Abstract
Background: We investigated our translation of The Mood Disorder Questionnaire (MDQ) as a
screening instrument for bipolar disorder in a psychiatric setting in Finland.
Methods: In a pilot study for the Jorvi Bipolar Study (JoBS), 109 consecutive non-schizophrenic
psychiatric out- and inpatients in Espoo, Finland, were screened for bipolar disorder using the
Finnish translation of the MDQ, and 38 of them diagnostically interviewed with the SCID.
Results: Forty subjects (37%) were positive in the MDQ screen. In the SCID interview, twenty
patients were found to suffer from bipolar disorder, of whom seven (70%) of ten patients with
bipolar I but only two (20%) of ten with bipolar II disorder had been previously clinically correctly
diagnosed. The translated MDQ was found internally consistent (alpha 0.79) and a feasible
screening tool.
Conclusions: Bipolar disorder, particularly type II, remains commonly unrecognized in psychiatric
settings. The Mood Disorder Questionnaire is a feasible screen for bipolar disorder, which could
well be integrated into psychiatric routine practice.
Background
Although bipolar disorder is a major public health issue,
it is commonly unrecognized even in psychiatric settings
[1,2]. Feasible screening instruments are needed to
improve recognition and diagnosis of the various forms of
the illness. The Mood Disorder Questionnaire [3] is a
recently developed and simple screening method already
validated in a US multicenter study. The instrument was
found to have relatively good sensitivity (0.73) and very
good specificity (0.90) in samples comprising mostly
patients with uni- and bipolar mood disorders in aca-
demic centers [3]; in a further general population study
the sensitivity turned out to be very low (0.28), but specif-
icity (0.97) remarkably high [4]. The instrument has so far
been little investigated by others than its developers.
In the present pilot study, using our Finnish translation of
the Mood Disorder Questionnaire among unselected psy-
chiatric patients, we investigated its psychometric and
screening properties, and its feasibility in improving rec-
ognition of type I and II bipolar disorder.
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Methods
The present investigation was a pilot study for the ongoing
Jorvi Bipolar Study (JoBS). The screening for bipolar dis-
order was conducted at the Department of Psychiatry at
Jorvi Hospital, part of the Helsinki University Central
Hospital, from 1st–31st October, 2001. The Department
has a catchment area of approximately 250 000 inhabit-
ants, but this pilot study was conducted only in two
selected community mental health centres (Leppävaara
and Kirkkonummi), and in the psychiatric outpatient
clinic of Jorvi Hospital and three of its psychiatric wards.
The whole JoBS project has been evaluated and accepted
in the Ethics Committee of the Helsinki and Uusimaa
Hospital District, and it complies with the principles of
the Helsinki Declaration.
Three patient groups were screened: (a) all new patients
who were referred to treatment in the Department of Psy-
chiatry; (b) all patients who had earlier received treatment
in the Department, but now had a new referral, and (c)
those already in contact with the facilities, without a clin-
ical diagnosis of ICD-10 schizophrenia, and now showing
signs of deteriorating clinical state after at least two
months of limited or no symptoms. The aim was to
include all incident episodes of bipolar disorder among
patients receiving treatment.
The Mood Disorder Questionnaire [3] is a short self-
report screening instrument, and was translated into Finn-
ish by the authors. The first question includes 13 items,
symptoms or behaviors related to a manic or hypomanic
syndrome. The second question asks whether several of
the symptoms have been experienced during the same
time period, and the third asks about resulting problems,
classified as minor, moderate or serious. The screen is
regarded positive when seven or more positive symptoms
have occurred, several within the same episode, causing
moderate to severe problems. If the MDQ was negative,
the attending professional was also asked whether bipolar
disorder might be present despite a negative screen (clini-
cal suspicion).
All patients with a positive screen or clinically suspected
of having bipolar disorder were invited to be interviewed
with the Structured Clinical Interview for DSM-IV Axis I
Disorders, Clinician Version, SCID-CV [5]. In addition, a
systematic sample of every third patient with 4–6 positive
items in question 1 of the MDQ was drawn from each set-
ting. All interviewers were either psychiatrists or residents
with several years experience in psychiatry and relevant
training. The first two authors supervised the diagnostic
process.
Results
Screening phase
The group of eligible patients comprised 113 subjects, of
whom two (2%) refused and two (2%) were excluded
because of not speaking Finnish. Altogether 109 (96%)
patients were screened. Their mean age was 37.9 ± 11.4
years, and 56 (51%) were female. Forty subjects (37%)
were positive in the MDQ. Twenty-nine (27%) subjects
had negative MDQ but 4–6 positive items in question 1.
This latter group included four of the five subjects (5% of
the total) with negative MDQ who were clinically sus-
pected of possibly suffering from bipolar disorder.
The frequency of positive responses to the various symp-
tom items of question 1 ranged from 27% (more social)
to 74% (racing thoughts). In the vast majority of those
reporting seven or more items, several symptoms had
occurred within the same time period (in 87%), and mod-
erate to serious problems were present (in 91%). The
internal consistency of the translated instrument was
found to be good (Cronbach's alpha 0.79).
Diagnostic findings
Of those eligible for diagnostic interview, 38 of 51 (75%)
agreed to participate. Of those interviewed, 20 (53%)
were diagnosed with bipolar disorder: ten (26%, 5 males)
with type I and ten (26%, 3 males) with type II (Table 1).
The mean ages of the two groups were 38.2 ± 8.0 years and
39.1 ± 12.5 years, respectively. Using the SCID-interview
as the gold standard, the MDQ screening produced 9 false
positives (5 patients with unipolar MDD; one schizoaffec-
tive, brief psychotic, and personality disorders; plus an
amphetamine-induced psychosis) and three false negative
patients (one type I with < 7 acknowledged items, one
type II patient with only minor problems due to hypoma-
nia, and one type II with both). Less than half of those
diagnosed with bipolar disorder in the SCID interview
had had a ICD-10 diagnosis of bipolar disorder, mania or
hypomania, or bipolar schizoaffective disorders before
the interview. Of the bipolar I patients seven (70%) had a
relevant diagnosis before the interview, compared to only
two of the bipolar II patients (20%). Despite the small
sample size, the difference approached statistical signifi-
cance (Fisher's exact test, p = 0.07).
The properties of the MDQ as a screen within the 
diagnostically interviewed sample
In the ROC-analysis (Table 2, Additional file: 1) with the
standard cut-offs, sensitivity emerged as high (0.85), but
specificity only moderate (0.47). However, the optimal
cut-off within this sample was found to be eight symp-
toms but accepting also minor problems due to episodes
(sensitivity 0.90, specificity 0.59). Ignoring severity of
problems caused (question three) altogether resulted in
very low specificity.BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/8
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Discussion
We found the Mood Disorder Questionnaire to be a feasi-
ble method for improving recognition of bipolar disorder,
which has clearly been a problem. However, by defini-
tion, hypomania involves no marked impairment.
Whether necessitating moderate to severe problems to be
caused by it is useful in screening should be further inves-
tigated. Having minor problems might be enough.
This was a pilot study for the current Jorvi Bipolar Study
(JoBS). Several methodological limitations should be
noted, some suggesting caution in interpreting the find-
ings. The sample of patients screened with the Mood Dis-
order Questionnaire was not large (N = 109), albeit
probably representative of psychiatric in- and outpatients
in the area. The number of patients interviewed with SCID
was relatively small. Those interviewed with SCID were
not a random sample of all patients screened, but a sam-
ple of cases suspected of having bipolar disorder on the
basis of the finding in the MDQ, or other clinical factors.
The screen thus influenced whether a diagnostic interview
was conducted. It is therefore clear that the ROC-analysis
overestimated sensitivity and underestimated specificity,
and cannot be compared with respective estimates from
unselected samples [3]. It only shows that within this
sample, the optimal cut-offs would have been different.
Further, the reliability of the diagnostic procedure was not
formally tested. Finally, the generalizability of our find-
ings within Finland, or to other countries, is not known.
Given the relatively good resources and interest in bipolar
disorder in the Jorvi psychiatric facilities, we expect recog-
nition to be at least not worse than elsewhere in Finland.
Our finding of underrecognition is comparable with those
from other countries [6–10].
The Mood Disorder Questionnaire appears to be a feasible
method for improving the recognition of bipolar disorder.
The internal consistency of the translated instrument was
almost as good (Cronbach's alpha 0.79 vs. 0.90) as in the
original validation study [3]. Our study population was
not a selected sample of patients with mood disorders, but
rather an ordinary sample of secondary care psychiatric
patients, schizophrenia excluded. Nevertheless, our prev-
alences of positive items (27–74% vs. 34–77%) and bipo-
lar disorder (53% vs. 55%) were similar to the original
validation study figures, although the proportion of type
II disorder was higher (50% vs. 24%) in ours. In the third
published study of the MDQ [11] that focused on its fac-
tor structure, rates of positive items were convergent,
although slightly lower (12–65%) among private practice
mood disorder patients.
The most important public health problem related to
bipolar disorder is the remarkable proportion of patients
who have unrecognised bipolar II disorder [6–10]. The
majority of unrecognised patients in our sample, too, had
bipolar II disorder. It is therefore vital that the MDQ is
also sensitive to bipolar II. Hypomania, as defined in the
DSM-IV, must not be related to marked impairment [12].
Thus the last question in the MDQ, necessitating moder-
ate to severe problems due to episodes, appears to have a
higher threshold for impairment. In our diagnosed sam-
ple, accepting minor impairment too, but necessitating
eight symptoms, was found to be the optimal cut-off. Nev-
ertheless, even using the standard cut-offs several patients
with previously unrecognised bipolar II disorders were
identified, and in fact, ignoring the last question com-
pletely resulted in lower specificity. It is to be noted that
our findings are based only on ten bipolar II patients and
an enriched subsample of patients with bipolar disorder.
We suggest that the optimal cut-offs for bipolar II disor-
ders should be further investigated in larger and represent-
ative patient samples.
Conclusions
The Mood Disorder Questionnaire seems to be a feasible
method for improving the recognition of bipolar disorder.
Whether screening is actually beneficial is related to the
quality of current routine diagnostic procedures. It is use-
ful in psychiatric settings only if recognition without it is
a problem, which according to our findings is certainly
true. The proportion of previously unrecognised cases was
Table 1: Findings of the Mood Disorder Questionnaire screening vs. diagnostic SCID-interview (N = 37)a
MDQ-screening
Diagnostic SCID-interview negative positive total
No bipolar disorder 8 9 17
Bipolar disorder, type I 1 9 10
Bipolar disorder, type II 2 8 10
11 26 37
a One case excluded due to missing response to question 3.Publish with BioMed Central    and   every 
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particularly high in bipolar II disorders, only a few of
whom had previously received the correct diagnosis. Our
findings support the value and feasibility of screening for
bipolar disorder with the MDQ in psychiatric settings.
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